Jodie Pope Morrison Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jodie Pope Morrison.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jodie Pope Morrison. Jodie Pope Morrison is Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Interim CEO in KERYX BIOPHARMACEUTICALS INC ($KERX) and President and CEO in Tokai Pharmaceuticals Inc ($TKAI) and Director in AILERON THERAPEUTICS INC ($ALRN) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
Latest Insider Trading Transactions of Jodie Pope Morrison
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALRN, AKBA, ELDN, KERX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 1.29 | 96,000 | 123,840 | 96,000 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 21 2019 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 0.86 | 25,000 | 21,500 | 25,000 | |
Jun 10 2019 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
Jun 10 2019 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Grant | A | 0.00 | 13,700 | 0 | 58,619 | 44.9 K to 58.6 K (+30.50 %) | |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 16.17 | 18,716 | 302,638 | 18,716 | |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Grant | A | 0.00 | 44,919 | 0 | 44,919 | 0 to 44.9 K |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Option Exercise | D | 0.00 | 110,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Sell | D | 0.00 | 120,000 | 0 | 0 | 120 K to 0 (-100.00 %) |
Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Grant | A | 0.00 | 10,000 | 0 | 120,000 | 110 K to 120 K (+9.09 %) |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
May 14 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Grant | A | 0.00 | 100,000 | 0 | 110,000 | 10 K to 110 K (+1,000.00 %) |
May 14 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Grant | A | 0.00 | 100,000 | 0 | 110,000 | 10 K to 110 K (+1,000.00 %) |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Director | Option Exercise | A | 6.56 | 30,000 | 196,800 | 30,000 | |
Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 23 2016 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Director | Option Exercise | A | 6.05 | 50,000 | 302,500 | 50,000 | |
Jan 08 2016 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 1.37 | 20,000 | 27,400 | 37,878 | |
Jan 08 2016 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 0.63 | 8,015 | 5,049 | 0 | |
Jan 08 2016 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 1.37 | 20,000 | 27,400 | 57,566 | 37.6 K to 57.6 K (+53.24 %) |
Jan 08 2016 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 0.63 | 8,015 | 5,049 | 37,566 | 29.6 K to 37.6 K (+27.12 %) |
Dec 17 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | A | 9.65 | 189,000 | 1,823,850 | 189,000 | |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 1.37 | 3,000 | 4,110 | 57,878 | |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 0.63 | 7,000 | 4,410 | 8,015 | |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 1.58 | 564 | 891 | 312,736 | |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 1.58 | 12,000 | 18,960 | 313,300 | |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 1.37 | 3,000 | 4,110 | 29,551 | 26.6 K to 29.6 K (+11.30 %) |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 0.63 | 7,000 | 4,410 | 26,551 | 19.6 K to 26.6 K (+35.80 %) |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Sell | S | 13.70 | 564 | 7,727 | 19,551 | 20.1 K to 19.6 K (-2.80 %) |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 1.58 | 564 | 891 | 20,115 | 19.6 K to 20.1 K (+2.88 %) |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Sell | S | 13.70 | 12,000 | 164,400 | 19,551 | 31.6 K to 19.6 K (-38.03 %) |
Jul 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 1.58 | 12,000 | 18,960 | 31,551 | 19.6 K to 31.6 K (+61.38 %) |
Jul 24 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 0.63 | 7,426 | 4,678 | 15,015 | |
Jul 24 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 2.31 | 2,574 | 5,946 | 0 | |
Jul 24 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 0.63 | 7,426 | 4,678 | 19,551 | 12.1 K to 19.6 K (+61.25 %) |
Jul 24 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 2.31 | 2,574 | 5,946 | 12,125 | 9.6 K to 12.1 K (+26.95 %) |
Jun 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 1.58 | 8,000 | 12,640 | 325,300 | |
Jun 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | M | 1.58 | 8,000 | 12,640 | 333,300 | |
Jun 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Sell | S | 13.70 | 8,000 | 109,600 | 9,551 | 17.6 K to 9.6 K (-45.58 %) |
Jun 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 1.58 | 8,000 | 12,640 | 17,551 | 9.6 K to 17.6 K (+83.76 %) |
Jun 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Sell | S | 13.83 | 8,000 | 110,640 | 9,551 | 17.6 K to 9.6 K (-45.58 %) |
Jun 30 2015 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Buy | M | 1.58 | 8,000 | 12,640 | 17,551 | 9.6 K to 17.6 K (+83.76 %) |
Oct 17 2014 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | A | 13.25 | 134,134 | 1,777,276 | 134,134 | |
Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | A | 1.58 | 165,251 | 261,097 | 165,251 |
Page: 1